Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)
Media ReleaseCOPENHAGEN, Denmark; June 15, 2025 Results from the EPCORE® NHL-2 trial…
Indian Investment into UK At an All Time High
Grant Thornton's India Meets Britain Tracker 2025 to be unveiled at IGF…
TOP ENGINEER MAPS OUT GENESIS STRATEGY FOR HIGH PERFORMANCE, NEXTGEN POWERTRAINS
Frankfurt, Germany, Tuesday 10th June 2025: From developing new propulsion systems to…
KINECTRICS Signs Contract with HIGHVOLT to Significantly Expand its High Voltage Cable Testing Capacity
DRESDEN, Germany, June 5, 2025 /PRNewswire/ --KINECTRICS announced today a significant expansion…
Hollyland introduces the all-new LARK A1 wireless microphone, the perfect combination of professional sound quality and high value
The gateway to professional audio starts at $34.9. SHENZHEN, China, May 27,…
